Subscribe To
Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference
CAMBRIDGE, Mass., March 01, 2023 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a novel platform of orally delivered anti-inflammatory medicines acting on the small intestinal axis, SINTAX, today announced that Mark Plinio, J.D., Chief Commercial Officer will participate in a dermatology panel at the Cowen 43rd Annual Health Care […] The post Evelo Biosciences to Participate in the Cowen 43rd Annual Health Care Conference appeared firs...
Read More
Posted: Mar 1 2023, 11:00
Author Name: forextv
Views: 082252